The Micron Group

The Micron Group is a well-established, privately-held UK-based CRO with a strong operational history dating back to 1996. It offers a full suite of clinical development services, leveraging a 'global reach, local focus' model to support clients from discovery through commercialization. The company demonstrates stability through high staff retention and positions itself as a nimble, faster alternative to large CROs, with a notable focus on infectious diseases and antimicrobial resistance (AMR). Its business model is purely service-based, generating revenue from contracted research and consultancy work.

Integrated CRO service platform encompassing clinical trial management, regulatory consultancy, data management, and medical writing. Utilizes proprietary/partnered software for data analytics (e.g., MARS for microbiology reports) and feasibility intelligence (TrialHub partnership) to enhance trial speed and insights.

Operates in the highly competitive global CRO market, competing against large public players (e.g., IQVIA, ICON) with greater scale and resources, as well as numerous small niche providers. Differentiates through a specialist focus on infectious diseases/AMR, high staff retention, and claims of significantly faster patient recruitment as a more agile, mid-sized partner.